Buy Portrazza (necitumumab) Online For Sale
$9,564.88
DISEASE INDICATIONS: Lung Cancer
MANUFACTURER: Eli Lilly Nederland B.V.
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Portrazza (necitumumab) is a medication approved for the treatment of advanced squamous non-small cell lung cancer. It is used in combination with the chemotherapies gemcitabine and cisplatin.